214 related articles for article (PubMed ID: 8346278)
1. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.
Webb S; Nahum AE
Phys Med Biol; 1993 Jun; 38(6):653-66. PubMed ID: 8346278
[TBL] [Abstract][Full Text] [Related]
2. Some characteristics of tumour control probability for heterogeneous tumours.
Ebert MA; Hoban PW
Phys Med Biol; 1996 Oct; 41(10):2125-33. PubMed ID: 8912385
[TBL] [Abstract][Full Text] [Related]
3. A TCP model incorporating setup uncertainty and tumor cell density variation in microscopic extension to guide treatment planning.
Jin JY; Kong FM; Liu D; Ren L; Li H; Zhong H; Movsas B; Chetty IJ
Med Phys; 2011 Jan; 38(1):439-48. PubMed ID: 21361212
[TBL] [Abstract][Full Text] [Related]
4. Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data.
Levegrün S; Jackson A; Zelefsky MJ; Skwarchuk MW; Venkatraman ES; Schlegel W; Fuks Z; Leibel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1064-80. PubMed ID: 11704332
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of adaptive radiotherapy of bladder cancer by image-based tumour control probability modelling.
Wright P; Muren LP; Høyer M; Malinen E
Acta Oncol; 2010 Oct; 49(7):1045-51. PubMed ID: 20831494
[TBL] [Abstract][Full Text] [Related]
6. Microdosimetry and radiocurability: modelling targeted therapy with beta-emitters.
Nahum AE
Phys Med Biol; 1996 Oct; 41(10):1957-72. PubMed ID: 8912374
[TBL] [Abstract][Full Text] [Related]
7. A new method for optimum dose distribution determination taking tumour mobility into account.
Stavrev PV; Stavreva NA; Round WH
Phys Med Biol; 1996 Sep; 41(9):1679-89. PubMed ID: 8884905
[TBL] [Abstract][Full Text] [Related]
8. Potential advantages of protons over conventional radiation beams for paraspinal tumours.
Isacsson U; Hagberg H; Johansson KA; Montelius A; Jung B; Glimelius B
Radiother Oncol; 1997 Oct; 45(1):63-70. PubMed ID: 9364633
[TBL] [Abstract][Full Text] [Related]
9. Comments on the article 'A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density'.
Stavreva NA; Stavrev PV; Round WH
Phys Med Biol; 1995 Oct; 40(10):1735-8. PubMed ID: 8532753
[No Abstract] [Full Text] [Related]
10. The effects of radiotherapy treatment uncertainties on the delivered dose distribution and tumour control probability.
Booth JT; Zavgorodni SF
Australas Phys Eng Sci Med; 2001 Jun; 24(2):71-8. PubMed ID: 11560173
[TBL] [Abstract][Full Text] [Related]
11. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
Keall PJ; Webb S
Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
[TBL] [Abstract][Full Text] [Related]
12. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study.
Søvik A; Malinen E; Bruland ØS; Bentzen SM; Olsen DR
Phys Med Biol; 2007 Jan; 52(2):499-513. PubMed ID: 17202629
[TBL] [Abstract][Full Text] [Related]
13. Optimization of tumour control probability for heterogeneous tumours in fractionated radiotherapy treatment protocols.
Levin-Plotnik D; Hamilton RJ
Phys Med Biol; 2004 Feb; 49(3):407-24. PubMed ID: 15012010
[TBL] [Abstract][Full Text] [Related]
14. Tumour volume distribution can yield information on tumour growth and tumour control.
Schneider U; Besserer J
Z Med Phys; 2022 May; 32(2):143-148. PubMed ID: 34119384
[TBL] [Abstract][Full Text] [Related]
15. Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression.
Fenwick JD
Phys Med Biol; 1998 Aug; 43(8):2159-78. PubMed ID: 9725596
[TBL] [Abstract][Full Text] [Related]
16. A mathematical approach to optimizing the radiation dose distribution in heterogeneous tumours.
Stavreva NA; Stavrev PV; Round WH
Acta Oncol; 1996; 35(6):727-32. PubMed ID: 8938221
[TBL] [Abstract][Full Text] [Related]
17. Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung dose.
Nielsen TB; Hansen O; Schytte T; Brink C
Acta Oncol; 2014 Jan; 53(1):119-25. PubMed ID: 23627917
[TBL] [Abstract][Full Text] [Related]
18. A general tumour control probability model for non-uniform dose distributions.
González SJ; Carando DG
Math Med Biol; 2008 Jun; 25(2):171-84. PubMed ID: 18515259
[TBL] [Abstract][Full Text] [Related]
19. A heterogeneous dose distribution in simultaneous integrated boost: the role of the clonogenic cell density on the tumor control probability.
Strigari L; D'Andrea M; Abate A; Benassi M
Phys Med Biol; 2008 Oct; 53(19):5257-73. PubMed ID: 18758004
[TBL] [Abstract][Full Text] [Related]
20. Optimum parameters in a model for tumour control probability including interpatient heterogeneity.
Webb S
Phys Med Biol; 1994 Nov; 39(11):1895-914. PubMed ID: 15559999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
